Scottish Equity Partners

Jan Rutherford has joined Scottish Equity Partners’ (SEP) Healthcare & Life Sciences Group. She previously held the post of vicepresident of the life sciences division at Dresdner Kleinwort Capital in London, where she manged private equity investments in biotechnology and medical device companies across Europe and the US. Prior to this Rutherford worked in the European Business Development division of Quintiles Transnational. Before this, she spent five years working in international clinical research across a rang e of therapeutic indications for Merck Sharp & Dohme and Sandoz/Novartis. Jan Rutherford has a BSc in Pharmacy from Robert Gordon University, Aberdeen, and an MBA from Henley Management College. She has been registered as a pharmacist since 1993. The appointment coincides with the news that SEP has been appointed by Lloyds TSB Development Capital (LDC) to manage its healthcare and biotechnology portfolio. The firm will provide investment advice on LDC’s portfolio companies, which include the Dundee-based cancer therapeutics specialist Cyclacel.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare